Immunotherapy before targeted therapy improves survival in advanced melanoma

Researchers reported a 20 percent advantage in the two-year overall survival rate for subjects with advanced melanoma and a mutation in the BRAF gene, specifically a BRAF V600 mutation, who were initially treated with immunotherapy (72 percent survival rate) compared with subjects initially treated with targeted therapies (52 percent survival rate). The findings from the DREAMseq trial were published on September 28, 2022 in […]

Possibility of vaccine to prevent skin cancer

Research by the Oregon State University College of Pharmacy suggests that a vaccine stimulating production of a protein critical to the skin’s antioxidant network could help people bolster their defenses against skin cancer. Ultraviolet radiation from the sun leads to oxidative stress, which increases the risk of skin cancers such as melanoma, explains Arup Indra, professor of pharmaceutical sciences at […]